var data={"title":"Digoxin immune Fab: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Digoxin immune Fab: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6031?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=digoxin-immune-fab-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Digoxin immune Fab: Pediatric drug information&quot;</a> and <a href=\"topic.htm?path=digoxin-immune-fab-patient-drug-information\" class=\"drug drug_patient\">see &quot;Digoxin immune Fab: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160237\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>DigiFab</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160238\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>DigiFab</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160256\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Antidote</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160240\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">Each vial of digoxin immune Fab 40 mg will bind ~0.5 mg of digoxin.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Digoxin toxicity: Note:</b> Estimation of the dose is based on the body burden of digitalis. This may be calculated if the amount ingested is known or the post-distribution serum drug level is known (round the dose up to the nearest whole vial). If the amount ingested is unknown, general dosing guidelines should be used.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Acute ingestion of unknown amount:</b> IV: Initial: 10 vials; if needed, administer a second dose of 10 vials (20 vials total is adequate to treat most life-threatening ingestions).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Acute ingestion of known amount:</b> IV:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Based on number of tablets or capsules ingested:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <b>\n        <i>Step 1: Calculate total body load (mg)</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">\n      <i>Digoxin capsules:</i></p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Total body load (mg) = Amount (mg) digoxin capsules ingested</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">\n      <i>Digoxin tablets:</i></p>\n    <p style=\"text-indent:-2em;margin-left:10em;\">Total body load (mg) = 0.8 x (amount [mg] digoxin tablets ingested)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <b>\n        <i>Step 2: Calculate number of vials needed</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Digoxin Immune Fab Dose (vials) = Total body load (mg) / (0.5)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">\n      <b>Alternatively,</b> the following table gives an estimation of the number of vials needed based on the number of <b>digoxin </b>tablets or capsules ingested.</p>\n    <table border=\"1\" rules=\"all\" frame=\"border\">\n      <caption style=\"text-align:center;\">Approximate Dose of Digoxin Immune Fab (in vials) for Reversal of a Single Large Digoxin Overdose</caption>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <thead valign=\"top\">\n        <tr>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">Number of Digoxin Tablets or Capsules Ingested<sup>1</sup></p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">Dose of Digoxin Immune Fab</p>\n            <p style=\"text-indent:0em;\">(# of Vials)</p></th></tr></thead>\n      <tfoot valign=\"top\">\n        <tr>\n          <td colspan=\"2\" align=\"left\">\n            <p style=\"text-indent:0em;\">\n              <sup>1</sup>250 mcg tablets with 80% bioavailability or 200 mcg capsules with 100% bioavailability.</p></td></tr></tfoot>\n      <tbody valign=\"middle\">\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">25</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">10</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">50</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">20</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">75</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">30</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">100</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">40</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">150</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">60</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">200</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">80</p></td></tr></tbody></table>\n    \n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">\n      <b>Based on steady-state serum <span style=\"text-decoration: underline\">digoxin</span> concentration:</b> Adults: <b>Note:</b> If the calculated dose based on the digoxin concentration is different from the estimated dose based on the known ingested amount (if available), use the higher dose.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Digoxin Immune Fab Dose (vials) = (serum digoxin concentration [ng/mL] x weight [kg]) / <b>100</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Alternatively,</b> the following table gives an estimation of the number of vials needed based on the steady-state serum digoxin concentration.</p>\n    <table border=\"1\" rules=\"all\" frame=\"border\">\n      <caption style=\"text-align:center;\">Adult Dose Estimates of Digoxin Immune Fab (in # of Vials) From Steady-State Serum Digoxin Concentration</caption>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <thead valign=\"bottom\">\n        <tr>\n          <th rowspan=\"2\" valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">Patient Weight (kg)</p></th>\n          <th colspan=\"7\" valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">Serum Digoxin Concentration (ng/mL)</p></th></tr>\n        <tr>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1</p></th>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2</p></th>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">4</p></th>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">8</p></th>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">12</p></th>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">16</p></th>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">20</p></th></tr></thead>\n      <tbody valign=\"middle\">\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">40</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">0.5 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">3 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">5 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">7 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">8 vials</p></td></tr>\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">60</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">0.5 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">3 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">5 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">7 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">10 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">12 vials</p></td></tr>\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">70</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">3 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">6 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">9 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">11 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">14 vials</p></td></tr>\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">80</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">3 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">7 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">10 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">13 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">16 vials</p></td></tr>\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">100</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1 vial</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">4 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">8 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">12 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">16 vials</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">20 vials</p></td></tr></tbody></table>\n    \n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Chronic toxicity (serum digoxin concentration unavailable):</b> IV: Adults: 6 vials is adequate to reverse most cases of toxicity</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160250\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=digoxin-immune-fab-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Digoxin immune Fab: Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">Each vial of digoxin immune Fab 40 mg will bind ~0.5 mg of digoxin.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Digoxin toxicity: Note:</b> Estimation of the dose is based on the body burden of digitalis. This may be calculated if the amount ingested is known or the post-distribution serum drug level is known (round the dose up to the nearest whole vial). If the amount ingested is unknown, general dosing guidelines should be used.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Acute ingestion of unknown amount:</b> IV: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Acute ingestion of known amount:</b> IV: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Based on steady-state serum <span style=\"text-decoration: underline\">digoxin</span> concentration:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants and Children &le;20 kg: May require smaller doses; calculate the dose in milligrams (mg).</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Digoxin Immune Fab Dose (mg) = [(serum digoxin concentration [ng/mL] x weight [kg]) / <b>100</b>] x (digoxin immune Fab amount per vial [mg/vial])</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">\n      <b>\n        <i>Note:</i></b> Digoxin immune Fab amount per vial: 40 mg/vial.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Alternatively,</b> the following table gives an estimation of the amount of digoxin immune Fab needed based on the steady-state serum digoxin concentration.</p>\n    <table border=\"1\" rules=\"all\" frame=\"border\">\n      <caption style=\"text-align:center;\">Infants and Small Children Dose Estimates of Digoxin Immune Fab (in mg) From Steady-State Serum Digoxin Concentration</caption>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <thead valign=\"bottom\">\n        <tr>\n          <th rowspan=\"2\" valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">Patient Weight</p>\n            <p style=\"text-indent:0em;\">(kg)</p></th>\n          <th colspan=\"7\" valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">Serum Digoxin Concentration (ng/mL)</p></th></tr>\n        <tr>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1</p></th>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2</p></th>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">4</p></th>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">8</p></th>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">12</p></th>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">16</p></th>\n          <th valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">20</p></th></tr></thead>\n      <tfoot valign=\"top\">\n        <tr>\n          <td colspan=\"8\" valign=\"middle\" align=\"left\">\n            <p style=\"text-indent:0em;\">\n              <sup>1</sup>Dilution of reconstituted vial to 1 mg/mL may be desirable.</p></td></tr></tfoot>\n      <tbody valign=\"middle\">\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">0.4 mg<sup>1</sup></p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1 mg<sup>1</sup></p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1.5 mg<sup>1</sup></p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">3 mg<sup>1</sup></p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">5 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">6.5 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">8 mg</p></td></tr>\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">3</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1 mg<sup>1</sup></p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2.5 mg<sup>1</sup></p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">5 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">10 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">14 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">19 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">24 mg</p></td></tr>\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">5</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2 mg<sup>1</sup></p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">4 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">8 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">16 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">24 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">32 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">40 mg</p></td></tr>\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">10</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">4 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">8 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">16 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">32 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">48 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">64 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">80 mg</p></td></tr>\n        <tr>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">20</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">8 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">16 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">32 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">64 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">96 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">128 mg</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">160 mg</p></td></tr></tbody></table>\n    \n    <p style=\"text-indent:-2em;margin-left:4em;margin-top:2em;\">Children &gt;20 kg and Adolescents: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Chronic toxicity (serum digoxin concentration unavailable):</b> IV:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants and Children &lt;20 kg: 1 vial is adequate to reverse most cases of toxicity</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children &ge;20 kg and Adolescents: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160241\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160242\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling; however, use with caution since digoxin-digoxin immune Fab complex is renally eliminated. Patients should undergo prolonged monitoring for recurrence of toxicity.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F15796118\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160219\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution Reconstituted, Intravenous [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">DigiFab: 40 mg (1 ea)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160203\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160222\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">IV: Administer by slow IV infusion over at least 30 minutes. May also be given by bolus injection if cardiac arrest is imminent (infusion-related reaction may occur). Infants and small children who require very small doses can be administered reconstituted digoxin immune fab undiluted using a tuberculin syringe. Stopping the infusion and restarting at a slower rate may help if an infusion-related reaction occurs.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160220\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Digoxin toxicity:</b> Treatment of life-threatening or potentially life-threatening digoxin intoxication, including:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">- Acute digoxin ingestion (&ge;10 mg in adults; 4 mg [&gt;0.1 mg/kg] in children); resulting in serum concentration &ge;10 ng/mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">- Chronic ingestion leading to steady state digoxin concentrations &gt;6 ng/mL in adults or &gt;4 ng/mL in children</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">- Manifestations of life-threatening digoxin toxicity due to overdose (severe ventricular arrhythmias, progressive bradycardia, second or third degree heart block not responsive to atropine, serum potassium concentration &gt;5.5 mEq/L in adults or &gt;6 mEq/L in children)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160210\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cardiovascular: Orthostatic hypotension, phlebitis, ventricular tachycardia (patients with atrial fibrillation; due to digoxin withdrawal), worsening of heart failure (due to digoxin withdrawal)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Endocrine &amp; metabolic: Hypokalemia</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Hypersensitivity: Hypersensitivity reaction, serum sickness</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160225\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">There are no contraindications listed in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160207\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hypersensitivity reactions: Digoxin immune Fab is derived from ovine (sheep) Fab immunoglobulin fragments; hypersensitivity reactions (eg, anaphylactic or anaphylactoid reactions, delayed allergic reactions) are possible. Patients with allergies to sheep proteins and patients with prior exposure to ovine antibodies or ovine Fab may be at a higher risk for  anaphylactic reactions. In patients who develop an anaphylactic reaction, discontinue the infusion immediately and administer emergency care; balance the need for epinephrine against its potential risk in the setting of digitalis toxicity.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;text-align:justify;\">Processed with papain and may cause hypersensitivity reactions in patients allergic to papaya, other papaya extracts, papain, chymopapain, or the pineapple-enzyme bromelain. There may also be cross allergenicity with dust mite and latex allergens.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">&bull; Potassium imbalance: Patients experiencing acute digitalis toxicity may present with significant hyperkalemia due to shifting of potassium into the extracellular space. Upon treatment with digoxin immune Fab, potassium shifts back into the intracellular space and may result in hypokalemia.  Monitor potassium closely, especially during the first few hours after administration; treat hypokalemia cautiously when clinically indicated.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Heart failure (HF): In patients chronically maintained on digoxin for HF, administration of digoxin immune Fab may result in exacerbation of HF symptoms due to a reduction in digoxin serum concentration. If reinitiation is required, consider postponing until Fab fragments have been eliminated completely; elimination may take several days or longer, especially in patients with renal impairment.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Renal impairment: Use with caution in patients with renal failure (experience limited); the Fab-digoxin complex will be eliminated more slowly. Toxicity may recur; prolonged monitoring for recurrence of symptoms and evaluation of free (unbound) digoxin concentrations (if test available) may be warranted in this patient population.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299196\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6219862\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=9361&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160215\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160227\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted. In general, medications used as antidotes should take into consideration the health and prognosis of the mother; antidotes should be administered to pregnant women if there is a clear indication for use and should not be withheld because of fears of teratogenicity (Bailey, 2003).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F21121953\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">It is not known if digoxin immune fab is excreted in breast milk. The manufacturer recommends caution be exercised when administering to  nursing women.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160217\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Prior to the first dose of digoxin immune Fab evaluate serum potassium, serum digoxin concentration, and serum creatinine; closely monitor serum potassium (eg, hourly for 4-6 hours; at least daily thereafter), temperature, blood pressure, and electrocardiogram after administration. <b>Total serum digoxin concentrations will rise precipitously following administration of digoxin immune Fab due to the presence of the Fab-digoxin complex; because digoxin bound to Fab fragments cannot result in toxicity, this rise has no clinical meaning. </b> Therefore, avoid monitoring total serum digoxin concentrations until the Fab fragments have been eliminated completely;  this may be several days to weeks in patients with renal impairment (Ujhelyi, 1995). Monitor for volume overload in children &lt; 20 kg. Monitor for signs and symptoms of a hypersensitivity reaction.</p>\n    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">Patients with renal failure may experience a recurrence of toxicity; prolonged monitoring for recurrence of symptoms and evaluation of free (unbound) digoxin concentrations (if test available) may be warranted in this patient population.  </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160206\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Digoxin immune antigen-binding fragments (Fab) are specific antibodies for the treatment of digitalis intoxication in carefully selected patients; binds with molecules of digoxin and is then excreted by the kidneys and removed from the body.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160224\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Onset of action: IV: Digitalis toxicity: Improvement may be seen within 20 to 90 minutes (Betten, 2006)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: V<sub>d</sub>: 0.3 L/kg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Half-life elimination: 15 to 20 hours; may be increased up to 10-fold in patient with renal impairment</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine (concentrations declining within 5 to 7 days)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16323111\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution (reconstituted)</b> (DigiFab Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">40 mg (1): $4,057.20</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F160228\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Digibind (GB);</li>\n      <li>Digifab (SG);</li>\n      <li>DigiFab (TW)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Antman EM, Wenger TL, Butler VP Jr, et al, &ldquo;Treatment of 150 Cases of Life-Threatening Digitalis Intoxication With Digoxin-Specific Fab Antibody Fragments,&rdquo; <i>Circulation</i>, 1990, 81(6):1744-52. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/2188752/pubmed\" target=\"_blank\" id=\"2188752\">2188752</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Aruna AS and Jue SG, &ldquo;Digoxin Immune Fab Administration Following an Unexplained Increase in Serum Digoxin Concentration,&rdquo; <i>J Pharm Sci Technol</i>, 1994, 10:246-9. </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Betten DP, Vohra RB, Cook MD, et al. Antidote use in the critically ill poisoned patient. <i>J Intensive Care Med</i>. 2006;21(5):255-277.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/16946442/pubmed\" target=\"_blank\" id=\"16946442\">16946442</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bailey B, &quot;Are There Teratogenic Risks Associated With Antidotes Used in the Acute Management of Poisoned Pregnant Women?&quot; <i>Birth Defects Res A Clin Mol Teratol</i>, 2003, 67(2):133-40.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/12769509/pubmed\" target=\"_blank\" id=\"12769509\">12769509</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bateman DN, &quot;Digoxin-Specific Antibody Fragments: How Much and When?&quot; <i>Toxicol Rev</i>,  2004, 23(3):135-43.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/15862081 /pubmed\" target=\"_blank\" id=\"15862081 \">15862081 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bilbault P, Oubaassine R, Rahmani H, et al, &ldquo;Emergency Step-by-Step Specific Immunotherapy in Severe Digoxin Poisoning: An Observational Cohort Study,&rdquo; <i>Europ J Emerg Med</i>, 2009, 16(3):145-9.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/19262393/pubmed\" target=\"_blank\" id=\"19262393\">19262393</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cohen V, Jellinek SP, Teperikidis L, et al, &ldquo;Room-Temperature Storage of Medications Labeled for Refrigeration,&rdquo; <i>Am J Health-Syst Pharm</i>, 2007, 64(16):1711-15.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/17687059/pubmed\" target=\"_blank\" id=\"17687059\">17687059</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    DigiFab (digoxin immune fab [ovine]) [prescribing information]. West Conshohocken, PA: January 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Eyer F, Steimer W, Muller C, et al, &ldquo;Free and Total Digoxin in Serum During Treatment of Acute Digoxin Poisoning With Fab Fragments: Case Study,&rdquo; <i>Am J Crit Care</i>, 2010, 19(4):391-87.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/19875723/pubmed\" target=\"_blank\" id=\"19875723\">19875723</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hickey AR, Wenger TL, Carpenter VP, et al, &ldquo;Digoxin Immune Fab Therapy in the Management of Digitalis Intoxication: Safety and Efficacy Results of an Observational Surveillance Study,&rdquo; <i>J Am Coll Cardiol</i>, 1991, 17(3):590-8. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/1993775/pubmed\" target=\"_blank\" id=\"1993775\">1993775</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kaufman J, Leikin J, Kendzierski D, et al, &ldquo;Use of Digoxin Fab Immune Fragments in a Seven-Day-Old Infant,&rdquo; <i>Pediatr Emerg Care</i>, 1990, 6(2):118-21. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/2371148/pubmed\" target=\"_blank\" id=\"2371148\">2371148</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kockova R, Skvaril J, Cernohous M, et al, &ldquo;Five Year Two Center Retrospective Analysis of Patients With Toxic Digoxin Serum Concentration,&rdquo; <i>Internat J Cardiol</i>,  2011, 146(3):447-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/21109316/pubmed\" target=\"_blank\" id=\"21109316\">21109316</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Leikin J, Vogel S, Graft J, et al, &ldquo;Use of Fab Fragments of Digoxin-Specific Antibodies in the Therapy of Massive Digoxin Poisoning,&rdquo; <i>Ann Emerg Med</i>, 1985, 14(2):175-8. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/3970406/pubmed\" target=\"_blank\" id=\"3970406\">3970406</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Martiny SS, Phelps SJ, and Massey KL, &ldquo;Treatment of Severe Digitalis Intoxication With Digoxin-Specific Antibody Fragments, A Clinical Review,&rdquo; <i>Crit Care Med</i>, 1988, 16(6):629-35. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/3286119/pubmed\" target=\"_blank\" id=\"3286119\">3286119</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shumaik GM, Wu AW, and Ping AC, &ldquo;Oleander Poisoning: Treatment With Digoxin-Specific Fab Antibody Fragments,&rdquo; <i>Ann Emerg Med</i>, 1988, 17(7):732-5. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/3382077/pubmed\" target=\"_blank\" id=\"3382077\">3382077</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ujhelyi MR and Robert S, &ldquo;Pharmacokinetic Aspects of Digoxin-Specific Fab Therapy in the Management of Digitalis Toxicity,&rdquo; <i>Clin Pharmacokinet</i>, 1995, 28(6):483-93. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/7656506/pubmed\" target=\"_blank\" id=\"7656506\">7656506</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Varriale P and  Mossavi A, &ldquo;Rapid Reversal of Digitalis Delirium Using Digoxin Immune Fab Therapy,&rdquo; <i>Clin Cardiol</i>, 1995, 18(6):351-2.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/digoxin-immune-fab-drug-information/abstract-text/7664510/pubmed\" target=\"_blank\" id=\"7664510\">7664510</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9361 Version 97.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F160237\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F160238\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F160256\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F160240\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F160250\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F160241\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F160242\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F15796118\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F160219\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F160203\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F160222\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F160220\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F160210\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F160225\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F160207\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299196\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F6219862\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F160215\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F160227\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F21121953\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F160217\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F160206\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F160224\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F16323111\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F160228\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9361|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=digoxin-immune-fab-patient-drug-information\" class=\"drug drug_patient\">Digoxin immune Fab: Patient drug information</a></li><li><a href=\"topic.htm?path=digoxin-immune-fab-pediatric-drug-information\" class=\"drug drug_pediatric\">Digoxin immune Fab: Pediatric drug information</a></li></ul></div></div>","javascript":null}